DD vs EBS
Dupont De Nemours Inc (DD) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. EBS currently screens at market cap $416.4M.
Not investment advice. Open the DD and EBS stock pages for the full models.
Not investment advice.